Unilever plc (UL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UL SEC filings page.
Unilever plc (UL) reported $59.3B in revenue for fiscal year 2025, up 9.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Unilever plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Unilever plc has an operating margin of 17.9%, meaning the company retains $18 of operating profit per $100 of revenue. This strong profitability earns a score of 86/100, reflecting efficient cost management and pricing power. This is up from 16.8% the prior year.
Unilever plc's revenue grew 9.1% year-over-year to $59.3B, a solid pace of expansion. This earns a growth score of 37/100.
Unilever plc has a moderate D/E ratio of 1.55. This balance of debt and equity financing earns a leverage score of 32/100.
Unilever plc's current ratio of 0.79 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Unilever plc converts 13.7% of revenue into free cash flow ($8.1B). This strong cash generation earns a score of 77/100.
Unilever plc earns a strong 61.0% return on equity (ROE), meaning it generates $61 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is up from 28.7% the prior year.
Unilever plc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Unilever plc generates $0.88 in operating cash flow ($9.8B OCF vs $11.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Unilever plc earns $8.83 in operating income for every $1 of interest expense ($10.6B vs $1.2B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Unilever plc generated $59.3B in revenue in fiscal year 2025. This represents an increase of 9.1% from the prior year.
Unilever plc's EBITDA was $12.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 15.5% from the prior year.
Unilever plc reported $11.1B in net income in fiscal year 2025. This represents an increase of 86.9% from the prior year.
Unilever plc earned $5.07 per diluted share (EPS) in fiscal year 2025. This represents an increase of 89.8% from the prior year.
Cash & Balance Sheet
Unilever plc generated $8.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 3.4% from the prior year.
Unilever plc held $4.6B in cash against $28.3B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Unilever plc's gross margin was 46.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Unilever plc's operating margin was 17.9% in fiscal year 2025, reflecting core business profitability. This is up 1.1 percentage points from the prior year.
Unilever plc's net profit margin was 18.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.8 percentage points from the prior year.
Unilever plc's ROE was 61.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 32.2 percentage points from the prior year.
Capital Allocation
Unilever plc invested $981.1M in research and development in fiscal year 2025. This represents an increase of 6.3% from the prior year.
Unilever plc invested $1.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.3% from the prior year.
Not reported for fiscal year 2025.
UL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.3B+9.1% | $54.3B-5.0% | $57.2B-11.0% | $64.3B+8.3% | $59.4B-4.3% | $62.0B+6.3% | $58.4B-0.1% | $58.4B-9.6% | $64.6B+16.1% | $55.6B-3.8% | $57.8B |
| Cost of Revenue | $31.4B+8.6% | $29.0B-10.3% | $32.3B-16.0% | $38.4B+12.2% | $34.2B-2.4% | $35.1B+7.4% | $32.7B-0.6% | $32.9B-10.3% | $36.6B+14.9% | $31.9B-4.7% | $33.5B |
| Gross Profit | $27.8B+9.7% | $25.4B+1.9% | $24.9B-3.7% | $25.9B+3.0% | $25.1B-6.8% | $27.0B+4.9% | $25.7B+0.6% | $25.5B-8.6% | $27.9B+17.7% | $23.7B-2.7% | $24.4B |
| R&D Expenses | $981.1M+6.3% | $923.3M-2.1% | $943.6M-2.9% | $971.4M+1.3% | $958.6M-2.0% | $978.4M | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $10.6B+16.1% | $9.1B-8.2% | $10.0B-13.5% | $11.5B+16.8% | $9.8B-3.0% | $10.2B+3.9% | $9.8B-32.5% | $14.5B+34.5% | $10.8B+30.8% | $8.2B+0.9% | $8.2B |
| EBITDA | $12.2B+15.5% | $10.6B-5.9% | $11.2B-17.4% | $13.6B+14.7% | $11.8B-6.2% | $12.6B+5.2% | $12.0B-29.5% | $17.0B+28.9% | $13.2B+35.0% | $9.8B+1.3% | $9.6B |
| Interest Expense | $1.2B+16.8% | $1.0B+0.9% | $1.0B+16.5% | $875.1M+57.5% | $555.7M-61.9% | $1.5B+58.3% | $921.7M+12.1% | $822.5M+0.2% | $821.1M+33.2% | $616.2M+10.0% | $560.3M |
| Income Tax | $2.9B+20.6% | $2.4B+9.7% | $2.2B-0.5% | $2.2B+1.0% | $2.2B-6.9% | $2.4B-7.4% | $2.5B-13.8% | $2.9B+46.8% | $2.0B-1.0% | $2.0B-4.8% | $2.1B |
| Net Income | $11.1B+86.9% | $5.9B-17.1% | $7.2B-12.2% | $8.2B+19.4% | $6.8B+0.3% | $6.8B+8.1% | $6.3B-41.2% | $10.7B+48.2% | $7.2B+32.4% | $5.5B+2.6% | $5.3B |
| EPS (Basic) | $5.08+89.6% | $2.68-16.4% | $3.210.0% | $3.21+21.7% | $2.64+1.2% | $2.60 | $2.41-39.6% | $4.00+54.7% | $2.58+33.9% | $1.93+2.8% | $1.88 |
| EPS (Diluted) | $5.07+89.8% | $2.67-16.5% | $3.20-0.1% | $3.20+21.8% | $2.63+1.3% | $2.59 | $2.40-39.7% | $3.99+55.0% | $2.57+34.0% | $1.92+2.8% | $1.87 |
| Diluted Shares (Avg) | 2.20B-1.5% | 2.23B-1.0% | 2.25B-12.1% | 2.56B-1.9% | 2.61B-0.8% | 2.63B | 2.63B-2.5% | 2.69B-4.2% | 2.81B-1.4% | 2.85B-0.1% | 2.86B |
Not reported in any period shown, so not listed: SG&A Expenses.
UL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $82.7B+0.2% | $82.5B-0.9% | $83.3B0.0% | $83.3B-2.0% | $85.0B+2.7% | $82.7B+13.7% | $72.8B+3.9% | $70.0B-3.4% | $72.5B+21.7% | $59.5B | N/A |
| Current Assets | $20.0B+0.8% | $19.9B+0.3% | $19.8B-3.4% | $20.5B+4.1% | $19.7B-0.3% | $19.8B+7.1% | $18.4B+4.0% | $17.7B-13.2% | $20.4B+39.4% | $14.7B | N/A |
| Cash & Equivalents | $4.6B-27.2% | $6.4B+38.1% | $4.6B-0.6% | $4.6B+19.7% | $3.9B-43.0% | $6.8B+44.4% | $4.7B+27.0% | $3.7B-7.2% | $4.0B+11.7% | $3.6B | N/A |
| Inventory | $4.7B-11.5% | $5.4B-5.4% | $5.7B-10.8% | $6.3B+19.7% | $5.3B-2.9% | $5.5B+16.7% | $4.7B-5.1% | $4.9B+3.4% | $4.8B+5.5% | $4.5B | N/A |
| Accounts Receivable | $8.6B+38.6% | $6.2B-2.6% | $6.4B-15.4% | $7.5B+23.0% | $6.1B+1.6% | $6.0B-19.6% | $7.5B+1.2% | $7.4B+18.3% | $6.3B+16.6% | $5.4B | N/A |
| Goodwill | $20.8B-10.0% | $23.1B-1.1% | $23.4B+1.0% | $23.1B+0.5% | $23.0B-0.7% | $23.2B+14.2% | $20.3B+2.1% | $19.9B-2.1% | $20.3B+9.1% | $18.6B | N/A |
| Total Liabilities | $62.1B+4.8% | $59.2B-1.8% | $60.3B+0.4% | $60.0B-4.2% | $62.6B+2.4% | $61.2B+7.0% | $57.2B+1.9% | $56.1B+1.7% | $55.2B+32.6% | $41.6B | N/A |
| Current Liabilities | $25.4B-2.7% | $26.1B+0.4% | $26.0B-4.4% | $27.2B-3.0% | $28.0B+11.4% | $25.2B+6.9% | $23.6B+2.0% | $23.1B-17.2% | $27.9B+28.5% | $21.7B | N/A |
| Non-Current Liabilities | $36.6B+10.8% | $33.1B-3.5% | $34.3B+4.4% | $32.8B-5.1% | $34.6B-3.8% | $36.0B+7.0% | $33.6B+1.7% | $33.0B+21.0% | $27.3B+37.0% | $19.9B | N/A |
| Long-Term Debt | $28.3B+17.3% | $24.1B-3.7% | $25.0B+7.3% | $23.3B-3.4% | $24.1B-6.4% | $25.8B+5.3% | $24.5B+0.6% | $24.4B+26.6% | $19.2B+66.8% | $11.5B | N/A |
| Total Equity | $18.2B-11.9% | $20.7B+3.3% | $20.0B-1.6% | $20.3B+5.1% | $19.4B+3.7% | $18.7B+26.1% | $14.8B+13.4% | $13.1B-20.3% | $16.4B-5.1% | $17.3B-1.2% | $17.5B |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | $20.4B-31.4% | $29.8B-6.9% | $32.0B+31.0% | $24.5B | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
UL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.8B-0.5% | $9.9B-5.5% | $10.4B+33.8% | $7.8B-13.7% | $9.0B-18.6% | $11.1B+21.7% | $9.1B+8.6% | $8.4B-11.5% | $9.5B+27.4% | $7.4B-6.6% | $8.0B |
| Depreciation & Amortization | $1.6B+12.0% | $1.4B+11.7% | $1.3B-39.0% | $2.1B+4.3% | $2.0B-19.2% | $2.5B+10.9% | $2.2B-12.3% | $2.5B+4.3% | $2.4B+57.6% | $1.5B+3.8% | $1.5B |
| Capital Expenditures | $1.7B+16.3% | $1.4B+8.2% | $1.3B-15.2% | $1.6B+24.2% | $1.3B+18.8% | $1.1B-28.6% | $1.5B-3.0% | $1.5B-16.1% | $1.8B-4.7% | $1.9B-6.1% | $2.0B |
| Free Cash Flow | $8.1B-3.4% | $8.4B-7.5% | $9.1B+46.1% | $6.2B-19.8% | $7.8B-22.5% | $10.0B+31.4% | $7.6B+11.2% | $6.9B-10.4% | $7.7B+38.4% | $5.5B-6.7% | $5.9B |
| Investing Cash Flow | -$3.7Bn/m | -$646.9Mn/m | -$2.5B-196.7% | $2.6Bn/m | -$3.7Bn/m | -$1.8Bn/m | -$2.5B-147.2% | $5.3Bn/m | -$7.1Bn/m | -$3.4Bn/m | -$3.8B |
| Financing Cash Flow | -$8.0Bn/m | -$7.2Bn/m | -$8.0Bn/m | -$9.5Bn/m | -$8.0Bn/m | -$7.1Bn/m | -$5.2Bn/m | -$13.9Bn/m | -$2.4Bn/m | -$3.2Bn/m | -$3.3B |
| Dividends Paid | $5.2B+16.9% | $4.5B-7.4% | $4.8B+4.2% | $4.6B-8.7% | $5.1B-3.0% | $5.2B+10.7% | $4.7B+1.4% | $4.7B-1.1% | $4.7B+23.6% | $3.8B+5.3% | $3.6B |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
UL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.9%+0.3pp | 46.7%+3.1pp | 43.5%+3.3pp | 40.2%-2.1pp | 42.3%-1.2pp | 43.5%-0.6pp | 44.0%+0.3pp | 43.7%+0.5pp | 43.3%+0.6pp | 42.6%+0.5pp | 42.2% |
| Operating Margin | 17.9%+1.1pp | 16.8%-0.6pp | 17.4%-0.5pp | 17.9%+1.3pp | 16.6%+0.2pp | 16.4%-0.4pp | 16.8%-8.0pp | 24.8%+8.1pp | 16.7%+1.9pp | 14.8%+0.7pp | 14.1% |
| Net Margin | 18.8%+7.8pp | 10.9%-1.6pp | 12.6%-0.2pp | 12.7%+1.2pp | 11.5%+0.5pp | 11.0%+0.2pp | 10.8%-7.6pp | 18.4%+7.2pp | 11.2%+1.4pp | 9.8%+0.6pp | 9.2% |
| Return on Equity | 61.0%+32.2pp | 28.7%-7.1pp | 35.8%-4.3pp | 40.2%+4.8pp | 35.4%-1.2pp | 36.6%-6.1pp | 42.6%-39.6pp | 82.2%+38.0pp | 44.2%+12.5pp | 31.7%+1.2pp | 30.5% |
| Return on Assets | 13.4%+6.2pp | 7.2%-1.4pp | 8.6%-1.2pp | 9.8%+1.8pp | 8.1%-0.2pp | 8.3%-0.4pp | 8.7%-6.6pp | 15.3%+5.3pp | 10.0%+0.8pp | 9.2% | N/A |
| Current Ratio | 0.790.0x | 0.760.0x | 0.760.0x | 0.75+0.1x | 0.70-0.1x | 0.780.0x | 0.780.0x | 0.770.0x | 0.73+0.1x | 0.68 | N/A |
| Debt-to-Equity | 1.55+0.4x | 1.17-0.1x | 1.25+0.1x | 1.15-0.1x | 1.25-0.1x | 1.38-0.3x | 1.65-0.2x | 1.87+0.7x | 1.17+0.5x | 0.67 | N/A |
| Liabilities-to-Equity | 3.41+0.5x | 2.86-0.1x | 3.01+0.1x | 2.95-0.3x | 3.240.0x | 3.28-0.6x | 3.86-0.4x | 4.30+0.9x | 3.37+1.0x | 2.41 | N/A |
| Asset Turnover | 0.72+0.1x | 0.660.0x | 0.69-0.1x | 0.77+0.1x | 0.70-0.1x | 0.75-0.1x | 0.800.0x | 0.83-0.1x | 0.890.0x | 0.93 | N/A |
| FCF Margin | 13.7%-1.8pp | 15.5%-0.4pp | 15.9%+6.2pp | 9.7%-3.4pp | 13.1%-3.1pp | 16.2%+3.1pp | 13.1%+1.3pp | 11.8%-0.1pp | 11.9%+1.9pp | 10.0%-0.3pp | 10.3% |
Note: The current ratio is below 1.0 (0.79), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Unilever plc UL | FY2025 | $59.3B | $11.1B | 18.8% | $144.3B | 55/100 |
| Colgate-Palmolive Company CL | FY2025 | $20.4B | $2.1B | 10.5% | $74.5B | 58/100 |
| Kimberly-Clark Corp. KMB | FY2025 | $16.4B | $2.0B | 12.3% | $35.5B | 52/100 |
| The Estee Lauder Companies Inc. EL | FY2026 | $15.0B | $182.0M | 1.2% | $37.6B | 36/100 |
| Kenvue Inc. KVUE | FY2025 | $15.1B | $1.5B | 9.7% | $36.6B | 51/100 |
| Church & Dwight Co., Inc. CHD | FY2025 | $6.2B | $736.8M | 11.9% | $24.9B | 56/100 |
Where Unilever plc Ranks
Frequently Asked Questions
What is Unilever plc's annual revenue?
Unilever plc (UL) reported $59.3B in total revenue for fiscal year 2025. This represents a 9.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Unilever plc's revenue growing?
Unilever plc (UL) revenue grew by 9.1% year-over-year, from $54.3B to $59.3B in fiscal year 2025.
Is Unilever plc profitable?
Yes, Unilever plc (UL) reported a net income of $11.1B in fiscal year 2025, with a net profit margin of 18.8%.
What is Unilever plc's EBITDA?
Unilever plc (UL) had EBITDA of $12.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Unilever plc have?
As of fiscal year 2025, Unilever plc (UL) had $4.6B in cash and equivalents against $28.3B in long-term debt.
What is Unilever plc's gross margin?
Unilever plc (UL) had a gross margin of 46.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Unilever plc's operating margin?
Unilever plc (UL) had an operating margin of 17.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Unilever plc's net profit margin?
Unilever plc (UL) had a net profit margin of 18.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Unilever plc's return on equity (ROE)?
Unilever plc (UL) has a return on equity of 61.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Unilever plc's free cash flow?
Unilever plc (UL) generated $8.1B in free cash flow during fiscal year 2025. This represents a -3.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Unilever plc's operating cash flow?
Unilever plc (UL) generated $9.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Unilever plc's total assets?
Unilever plc (UL) had $82.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Unilever plc's capital expenditures?
Unilever plc (UL) invested $1.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Unilever plc spend on research and development?
Unilever plc (UL) invested $981.1M in research and development during fiscal year 2025.
What is Unilever plc's current ratio?
Unilever plc (UL) had a current ratio of 0.79 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Unilever plc's debt-to-equity ratio?
Unilever plc (UL) had a debt-to-equity ratio of 1.55 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Unilever plc's liabilities-to-equity ratio?
Unilever plc (UL) had a liabilities-to-equity ratio of 3.41 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Unilever plc's return on assets (ROA)?
Unilever plc (UL) had a return on assets of 13.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Unilever plc's P/E ratio?
Unilever plc (UL) trades at 13.0x earnings, its market capitalization divided by $11.1B net income, FY2025. The market capitalization is $144.3B as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Unilever plc's price-to-sales ratio?
Unilever plc (UL) trades at 2.4x sales, its market capitalization divided by $59.3B revenue, FY2025. The market capitalization is $144.3B as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Unilever plc's Piotroski F-Score?
Unilever plc (UL) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Unilever plc's earnings high quality?
Unilever plc (UL) has an earnings quality ratio of 0.88x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Unilever plc cover its interest payments?
Unilever plc (UL) has an interest coverage ratio of 8.83x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Unilever plc?
Unilever plc (UL) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.